SYK

STRYKER CORP

Healthcare • NYSE • CIK 0000310764

Loading...

Market Cap
$105.61B
P/E (TTM)
28.3x
Rev Growth (TTM)
+8.5%
Net Margin (TTM)
14.4%
FCF Yield (TTM)
4.5%
FCF Margin (TTM)
18.2%
Figures as of June 30, 2026

Filings

Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.

10-Q2026 Q22026-07-31source
8-KEarnings2026-07-30source
8-KJun 20262026-06-26source
8-KMay 20262026-05-20source
10-Q2026 Q12026-05-11source
What your agent reads

Investor Relations

investors.stryker.com/financial-information/quarterly-results/default.aspx

Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.

Company-published, not SEC-audited

Earnings

Q2
2 months ago
8-K release
Revenue
$6.59B
+9.4%
Net Income
$1.28B
+44.3%
EPS
N/A
—
Earnings call2025 Q4· machine-transcribedtranscript
Most recent quarterly earnings snapshot

Cash Flow Health

Free Cash Flow8/8 positive
TTM$4.7B
Q2 '26
$1.1B+155%
Q1 '26
$415.0M-78%
FCF Margin
TTM18.2%
Q2 '2616.1%+133%
Sector: 0.7%Top 25%
OCF Margin
21.4%
OCF/NI1.48x
CapEx Coverage
6.7x
FCF Yield4.5%
FCF Growth (3Y)+25%
Cash Conversion Cycle
–
DSO: 53+DIO: 217−DPO: –
View Latest Filing →
Cash flow trends & capital efficiency

Capital Allocation

Total Shareholder Yield
TTM1.2%
Div Yield1.3%
+
Buybacknot disclosed
Dividend & Payout Metrics
Dividend Yield (TTM)1.3%
FCF Payout Ratio28.4%
Free Cash Flow (TTM)$4.7B
Capital Return / FCF28.0%
Shares Outstanding (YoY)0.3%
Est. Dividends Paid (TTM)$1.3B
Buyback data not disclosed in this company's filings.
Shows how management rewards shareholders

Valuation Metrics

Price-to-EarningsTTM
28.3x
Volatile
8Q: 41.8x-2270%
Valuation Lenses
Earnings
28.3x
vs – sector
Cash Flow
24.9x
EV/FCF vs –
Growth-Adj
1.0xPEG
Fair for growth
Quality-Adj
2.7P/E per %ROIC
ROIC: 10.5%
Shareholder Returns
Dividend
1.3%
Buyback
–
Total Yield
1.2%
Market Cap$105.61B
EV$117.08B
Multi-angle valuation analysis with sector context

Margins & Efficiency

ROIC 75th pctile
Profitability Cascade
Gross
65.0%
Operating
21.4%
Top 25% in sector
Net
14.4%
Margins Unknown
Return on Invested CapitalTTM
10.5%
Stable
+0.0% YoY8Q: 10.1%+3.6%
P25MedianP75
75th pctl (med: -7.4%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
15.5%
8Q: 14.7%
Asset Turnover
0.55x
8Q: 0.53x
Leverage (1+D/E)
1.62x
D/E: 0.62x
DuPont: 13.8% ≈ 10.5% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
6.74x
8Q:6.69x
-22.2%
Invested Cap Turn
0.72x
8Q:0.71x
-4.5%
CapEx Intensity
2.3%
8Q:2.2%
CapEx/Depreciation
0.51x
FCF vs Net Margin Gap+3.8 pts
Margin trends, ROIC, and capital efficiency

Balance Sheet & Solvency

ND/EBITDA 1.7x
Net Debt / EBITDA
1.7xNet Debt: $11.47B
Interest Coverage
9.6x
+Strong interest coverage: 9.6x
Leverage Metrics
Debt-to-Equity
0.62x
Balance sheet risk & solvency analysis

Related Research

3 related posts